Volume 22, Number 5—May 2016
Dispatch
Rickettsia sibirica mongolitimonae Infection, France, 2010–2014
Emmanouil Angelakis, Herve Richet, and Didier Raoult
Table
Epidemiologic and clinical characteristics of the main spotted fever group rickettsioses identified at the Unité de Recherche sur les Maladies Infectieuses et Tropicales Émergentes, Marseilles, France, 2010–2014*
| Characteristic | Rickettsia africae | R. conorii | R. slovaca | R. sibirica mongolitimonae |
|---|---|---|---|---|
| No. cases | 36 | 21 | 14 | 20 |
| Geographic location | Zimbabwe and South Africa | Algeria, France, Morocco, Portugal, South Africa | France | France, Spain |
| Median age ± SD (IQR), y | 58 ± 12 (31–80) | 53 ± 18 (10–80) | 36 ± 23 (6–65) | 43 ± 21 (2–70) |
| Female sex | 14 (39) | 7 (33) | 9 (64) | 8 (40) |
| Recent travel |
36 |
17 |
0 |
1 |
| Clinical signs | ||||
| Fever | 35 (97) | 21 (100) | 5 (36) | 20 (100) |
| Rash | 24 (67) | 20 (95) | 3 (21) | 19 (95) |
| Enlarged lymph nodes | 15 (42) | 3 (14) | 14 (100) | 12 (60) |
| Lymphadenopathy location | ||||
| Cervical | 1 (3) | 3 (14) | 14 (100) | 5 (25) |
| Inguinal | 14 (39) | 0 | 0 | 3 (15) |
| Axillary |
0 |
0 |
0 |
4 (20) |
| Eschar | 36 (100) | 18 (86) | 14 (100) | 20 (100) |
| Multiple eschars |
13 (36) |
0 |
0 |
3 (15) |
| Eschar location | ||||
| Scalp | 0 | 2 (10) | 14 (100) | 0 |
| Lower limbs | 32 (89) | 3 (14) | 0 | 7 (33) |
| Upper limbs | 2 (6) | 2 (10) | 0 | 4 (20) |
| Trunk | 2 (6) | 5 (24) | 0 | 3 (15) |
| Neck |
0 |
0 |
0 |
4 (20) |
| Lymphangitis |
0 |
0 |
0 |
7 (35) |
| Treatment (duration, d) | ||||
| Doxycycline | 34 (1–20) | 21 (7–21) | 12 (1–7) | 19 (7–14) |
| Amoxicillin | 2 (7) | None | None | None |
| Pristinamycin | None | 1 (7) | None | 1 (7) |
| Azithromycin | None | None | 2 (4) | None |
*Values are no. (%) patients unless otherwise indicated. IQR, interquartile range.
Page created: April 20, 2016
Page updated: April 20, 2016
Page reviewed: April 20, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.